{"uniprot":"Q2M2W7","gene":"C17orf58","name":"UPF0450 protein C17orf58","organism":"Homo sapiens (Human)","status":"dark","length":339,"sequence":"MTARAFWLLCLIVGSSPEAPVAERKTSPPHSRKPDSRGCPSAEETPGPRAQPLLEAPQRPRAAEVAPAARAWPDPRRRKPPPPADNQASFREAARAPAGPPGPRLAQAENRASPRREPASEDAPRRARSRALRFPAARPPALATEGSAGHAHPNRPRAAALAPGPAPAPPPRFSLSFGLSPPQRDAEPGAEPCARACRSDLDEREAFCESEFAVNGIVHDVDVLGAGIRLVTLLVDRDGLYKMNRLYLTPDGFFFRVHMLALDSSSCNKPCPEFKPGSRYIVMGHIYHKRRQLPTALLQVLRGRLRPGDGLLRSSSSYVKRFNRKREGQIQGAIHTQCI","function_summary":"A human extracellular modulator that uses a netrin-like OB-fold to bind partners with high affinity and anchor within collagen-rich matrices. By assembling and stabilizing pericellular complexes at the cell–matrix interface, it dampens signaling through the TGF-beta receptor pathway, likely by limiting ligand availability, stabilizing inactive receptor states, or promoting receptor complex clearance. Its mechanism is driven by a rigid extracellular binding platform that organizes matrix-associated assemblies to fine-tune signaling thresholds.","plain_language":"C17orf58 has barely been studied. The model's best guess: A human extracellular modulator that uses a netrin-like OB-fold to bind partners with high affinity and anchor within collagen-rich matrices. By assembling and stabilizing pericellular complexes at the cell–matrix interface, it dampens signaling through the TGF-beta receptor pathway, likely by limiting ligand availability, stabilizing inactive receptor states, or promoting receptor complex clearance.","uniprot_summary":"May be involved in TGF-beta pathway.","go_terms":{"molecular_function":[{"id":"GO:0005515","label":"protein binding"}],"biological_process":[{"id":"GO:0030512","label":"negative regulation of transforming growth factor beta receptor signaling pathway"}],"cellular_component":[{"id":"GO:0062023","label":"collagen-containing extracellular matrix"}]},"interpro":[{"id":"IPR008993","name":"Tissue inhibitor of metalloproteinases-like, OB-fold","type":"homologous_superfamily","start":187,"end":339},{"id":"IPR001134","name":"Netrin domain","type":"domain","start":193,"end":338},{"id":"IPR064080","name":"UPF0450 protein C17orf58-like domain","type":"domain","start":193,"end":338}],"reasoning":"I begin with the InterPro architecture. The C-terminal half of the protein is dominated by IPR008993 (Tissue inhibitor of metalloproteinases-like, OB-fold homologous superfamily, residues 187–339). Within this OB-fold scaffold sits IPR001134 (Netrin domain, residues 193–338), and the same span is annotated as IPR064080 (UPF0450 protein C17orf58-like domain, residues 193–338). This arrangement—an OB-fold core that forms a netrin-like module—creates a compact, disulfide-rich extracellular fold specialized for avid protein–protein interactions and matrix association. The OB-fold/netrin architecture is well-suited for high-affinity binding to extracellular ligands and receptors, and it frequently underlies secreted or pericellular inhibitors and modulators rather than intracellular enzymes.\n\nThis OB-fold–netrin module causally supports GO:0005515 protein binding as the molecular function: the fold confers a rigid binding platform that captures extracellular partners with high specificity. The absence of catalytic motifs and the presence of a matrix-oriented OB-fold argue that the protein acts through binding and modulation rather than enzymatic turnover.\n\nFrom this binding-centric mechanism, I infer its role in signaling control. The OB-fold/netrin module is classically used to tune pathways at the cell surface and within the extracellular matrix. Such a module can sequester or scaffold components of the TGF-beta pathway, thereby dampening receptor activation and downstream SMAD signaling. This mechanistic logic aligns with GO:0030512 negative regulation of transforming growth factor beta receptor signaling pathway: by binding to matrix-tethered complexes or receptor-associated adaptors, the protein attenuates signal flux through the TGF-beta axis.\n\nThe cellular context follows directly from the fold and process. OB-fold/netrin architectures are archetypal of secreted/pericellular proteins that embed into or associate with extracellular scaffolds. This supports localization to the GO:0062023 collagen-containing extracellular matrix, where the protein can access and modulate matrix-bound receptors and ligands. A matrix-tethered modulator situated at the cell–matrix interface provides the spatial vantage point necessary to suppress TGF-beta receptor signaling.\n\nPutting these elements together yields a mechanistic hypothesis. The OB-fold/netrin core forms a stable extracellular binding hub that anchors within collagen-rich matrices. By docking to matrix components and to receptor–ligand assemblies, it likely reduces the effective activity of TGF-beta receptor complexes—either by limiting ligand availability, stabilizing inactive receptor states, or promoting endocytic clearance. Consequently, it functions as a secreted/pericellular modulator that binds partners to restrain TGF-beta signaling.\n\nFrom this model, I hypothesize interaction partners that fit the matrix-tethered signaling checkpoint: extracellular TGF-beta ligands and receptor ectodomains at the cell surface; collagen IV and fibronectin as matrix footholds; and pericellular regulators that cooperate with OB-fold modules. These associations would collectively position the protein to fine-tune TGF-beta pathway output in the extracellular milieu.","category":"dark","control_evaluation":null,"validation_plan":null,"structure":{"source":"AlphaFold DB","pdb":"/structures/AF-Q2M2W7.pdb","alphafold":"https://alphafold.ebi.ac.uk/entry/Q2M2W7"},"links":{"uniprot":"https://www.uniprot.org/uniprotkb/Q2M2W7/entry","atlas":"/p/Q2M2W7"},"provenance":{"model":"BioReason-Pro (ESM3 esm3-sm-open-v1)","source_list":"Pharos Tdark","note":"AI prediction, not experimentally verified"}}